Compare JDZG & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JDZG | SCNI |
|---|---|---|
| Founded | 2020 | 2003 |
| Country | China | Israel |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2M | 4.6M |
| IPO Year | 2024 | N/A |
| Metric | JDZG | SCNI |
|---|---|---|
| Price | $1.11 | $0.70 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 11.0K | ★ 49.7K |
| Earning Date | 04-17-2026 | 11-24-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.25 | ★ 0.26 |
| Revenue | ★ $2,567,741.00 | $1,147,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $4.63 | ★ $3.19 |
| Revenue Growth | 20.36 | ★ 303.87 |
| 52 Week Low | $1.12 | $0.80 |
| 52 Week High | $14.00 | $6.18 |
| Indicator | JDZG | SCNI |
|---|---|---|
| Relative Strength Index (RSI) | 28.84 | 29.48 |
| Support Level | $1.21 | $0.80 |
| Resistance Level | $1.28 | $0.90 |
| Average True Range (ATR) | 0.11 | 0.11 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 2.17 | 1.67 |
Jiade Ltd specializes in providing one-stop comprehensive education supporting services to adult education institutions, through a wide range of software platform and auxiliary solutions. Auxiliary solutions encompass exam administration services and teaching support services throughout the entire teaching cycle. Specifically, the company offers pre-enrollment guidance on school/major selection and application strategy development, training for entrance exams, and assistance in the application process. The company also provides offline tutoring, exam administration services, guidance on graduation thesis, and social practice assistance included in the one-stop comprehensive education supporting services in the People's Republic of China.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.